Pila Pharma AB (OSTO:PILA) Beta: -0.0650 (As of Jul. 05, 2026)


OSTO:PILA Pila Pharma AB OSTO:PILA
49 GF Score
Price kr1.24
GF Value kr1.83
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pila Pharma AB Beta?

Pila Pharma AB OSTO:PILA -1.20% 49 Beta is -0.0650 as of Jul. 05, 2026. GuruFocus rates OSTO:PILA with a GF Score™ of 49/100 and a GF Value™ of kr1.83 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-05), Pila Pharma AB's Beta is -0.0650.


Pila Pharma AB  (OSTO:PILA) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Pila Pharma AB Beta Related Terms


Pila Pharma AB Beta Historical Data

* Premium members only.

The historical data trend for Pila Pharma AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pila Pharma AB Beta Chart

Pila Pharma AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 1.49 1.24

Pila Pharma AB Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1.49 1.53 1.24

OSTO:PILA vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Pila Pharma AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pila Pharma AB Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pila Pharma AB's Beta distribution charts can be found below:

* The bar in red indicates where Pila Pharma AB's Beta falls into.


OSTO:PILA
49GF Score
Pila Pharma AB OSTO:PILA
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pila Pharma AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.0650 mean?
Pila Pharma AB (OSTO:PILA) has a Beta of -0.0650 as of Jul. 05, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Pila Pharma AB and its competitors.
Is Pila Pharma AB's Beta too high?
Pila Pharma AB's current Beta is -0.0650. Overall, Pila Pharma AB has a GF Score™ of 49/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pila Pharma AB's Beta compare to VRTX and REGN?
Pila Pharma AB's Beta of -0.0650 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Pila Pharma AB and its competitors. Pila Pharma AB's current Beta is -0.0650. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pila Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, Pila Pharma AB (OSTO:PILA) is currently considered Significantly Undervalued. The stock's GF Value™ is kr1.83, compared to a current price of kr1.24 — trading 32.5% below its estimated fair value. The current Beta is -0.0650. Pila Pharma AB's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Pila Pharma AB (OSTO:PILA), the current Beta is -0.0650 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pila Pharma AB (OSTO:PILA) Overvalued in 2026?

Based on GuruFocus' analysis, Pila Pharma AB stock appears to be undervalued. The current stock price of kr1.24 is trading 32.5% below its estimated GF Value™ of kr1.83. GuruFocus considers Pila Pharma AB to be Significantly Undervalued.

Key valuation signals for OSTO:PILA:

  • Beta: -0.0650
  • GF Value™: kr1.83 vs. price of kr1.24 (32.5% below fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the OSTO:PILA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pila Pharma AB Business Description

Address Norra Vallgatan 72, Malmo, SWE, 211 21
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
49GF Score

Get the complete analysis for OSTO:PILA

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.24
Price
kr1.83
GF Value